Medicofarma Biotech SA
WSE:MDB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medicofarma Biotech SA
Selling, General & Administrative
Medicofarma Biotech SA
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Selling, General & Administrative
-zł1.3m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nanogroup SA
WSE:NNG
|
Selling, General & Administrative
-zł5.9m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Selling, General & Administrative
-zł154m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-16%
|
|
|
S
|
Selvita SA
WSE:SLV
|
Selling, General & Administrative
-zł166.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Medicofarma Biotech SA
Glance View
Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.
See Also
What is Medicofarma Biotech SA's Selling, General & Administrative?
Selling, General & Administrative
-1.3m
PLN
Based on the financial report for Dec 31, 2024, Medicofarma Biotech SA's Selling, General & Administrative amounts to -1.3m PLN.
What is Medicofarma Biotech SA's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-33%
Over the last year, the Selling, General & Administrative growth was -73%. The average annual Selling, General & Administrative growth rates for Medicofarma Biotech SA have been -49% over the past three years , -33% over the past five years .
